Tumors of the hematopoietic and lymphoid tissues

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Tumors of the hematopoietic and lymphoid tissues | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Fatigue, fever, weight loss, night sweats, lymphadenopathy |
| Complications | Infection, anemia, thrombocytopenia, leukopenia |
| Onset | Variable, depending on the specific type |
| Duration | Chronic |
| Types | Leukemia, Lymphoma, Multiple myeloma, Myelodysplastic syndromes, Myeloproliferative neoplasms |
| Causes | Genetic mutations, radiation, chemical exposure, viral infections |
| Risks | Family history, age, immunosuppression, previous cancer treatment |
| Diagnosis | Blood tests, bone marrow biopsy, imaging studies |
| Differential diagnosis | Infection, autoimmune disease, benign hematologic conditions |
| Prevention | Avoidance of known risk factors |
| Treatment | Chemotherapy, radiation therapy, stem cell transplant, targeted therapy |
| Medication | N/A |
| Prognosis | Varies widely depending on type and stage |
| Frequency | Common |
| Deaths | N/A |
A type of tumor affecting blood and lymphoid tissues
Tumors of the hematopoietic and lymphoid tissues are a diverse group of neoplasms that affect the blood, bone marrow, lymph, and lymphatic system. These tumors are generally classified into two main categories: leukemias and lymphomas, although other types exist.
Classification[edit]
Tumors of the hematopoietic and lymphoid tissues are classified based on the type of cell from which they originate. The World Health Organization (WHO) classification system is commonly used and includes:
- Leukemias: These are cancers of the blood or bone marrow characterized by an abnormal increase of white blood cells. They are further divided into acute and chronic forms, and by the type of white blood cell affected (e.g., acute lymphoblastic leukemia, chronic myeloid leukemia).
- Lymphomas: These are cancers that originate in the lymphatic system. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma.
- Plasma cell neoplasms: These include multiple myeloma and plasmacytoma, which are characterized by the proliferation of plasma cells.
- Myelodysplastic syndromes: These are a group of disorders caused by poorly formed or dysfunctional blood cells.
- Myeloproliferative neoplasms: These are diseases of the bone marrow in which excess cells are produced.
Pathophysiology[edit]
The pathophysiology of these tumors involves genetic mutations that lead to uncontrolled cell growth. These mutations can be inherited or acquired. Environmental factors, such as exposure to radiation or certain chemicals, can also contribute to the development of these tumors.
Diagnosis[edit]
Diagnosis typically involves a combination of physical examination, blood tests, bone marrow biopsy, and imaging studies. Specific tests, such as flow cytometry and cytogenetic analysis, are used to identify the type of tumor and its characteristics.
Treatment[edit]
Treatment varies depending on the type and stage of the tumor. Common treatments include chemotherapy, radiation therapy, targeted therapy, and stem cell transplantation. The choice of treatment is influenced by the patient's age, overall health, and specific characteristics of the tumor.
Prognosis[edit]
The prognosis for patients with tumors of the hematopoietic and lymphoid tissues varies widely. Factors influencing prognosis include the type of tumor, stage at diagnosis, and response to treatment. Advances in treatment have improved outcomes for many patients.
See also[edit]
References[edit]
- Swerdlow, S. H., Campo, E., Harris, N. L., Jaffe, E. S., Pileri, S. A., Stein, H., ... & Vardiman, J. W. (Eds.). (2017). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer.
- American Cancer Society. (2023). Understanding Blood and Lymphatic System Cancers. Retrieved from [1]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


